CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques

Front Immunol. 2021 Oct 20:12:757811. doi: 10.3389/fimmu.2021.757811. eCollection 2021.

Abstract

Induction of broadly neutralizing antibodies (bNAbs) is a major goal for HIV vaccine development. HIV envelope glycoprotein (Env)-specific bNAbs isolated from HIV-infected individuals exhibit substantial somatic hypermutation and correlate with T follicular helper (Tfh) responses. Using the VC10014 DNA-protein co-immunization vaccine platform consisting of gp160 plasmids and gp140 trimeric proteins derived from an HIV-1 infected subject that developed bNAbs, we determined the characteristics of the Env-specific humoral response in vaccinated rhesus macaques in the context of CD4+ T cell depletion. Unexpectedly, both CD4+ depleted and non-depleted animals developed comparable Tier 1 and 2 heterologous HIV-1 neutralizing plasma antibody titers. There was no deficit in protection from SHIV challenge, no diminution of titers of HIV Env-specific cross-clade binding antibodies, antibody dependent cellular phagocytosis, or antibody-dependent complement deposition in the CD4+ depleted animals. These collective results suggest that in the presence of diminished CD4+ T cell help, HIV neutralizing antibodies were still generated, which may have implications for developing effective HIV vaccine strategies.

Keywords: B cell; CD4+ T cell; HIV - human immunodeficiency virus; antibody; neutralizing; rhesus; vaccine.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Vaccines*
  • Animals
  • Antibodies, Bacterial / biosynthesis
  • Antibodies, Bacterial / immunology
  • Antibodies, Viral / immunology
  • Antibody-Dependent Cell Cytotoxicity
  • Broadly Neutralizing Antibodies / biosynthesis*
  • Broadly Neutralizing Antibodies / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • Cross Reactions
  • Female
  • Germinal Center / immunology
  • HIV Antibodies / biosynthesis*
  • HIV Antibodies / immunology
  • HIV Envelope Protein gp160 / immunology
  • HIV-1 / immunology
  • Immunization, Secondary
  • Macaca mulatta / immunology*
  • Male
  • Phagocytosis
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / prevention & control
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / immunology
  • Vaccine Development
  • Vaccines, Synthetic
  • Viral Load
  • env Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • AIDS Vaccines
  • Antibodies, Bacterial
  • Antibodies, Viral
  • Broadly Neutralizing Antibodies
  • HIV Antibodies
  • HIV Envelope Protein gp160
  • Vaccines, Synthetic
  • env Gene Products, Human Immunodeficiency Virus
  • gp140 envelope protein, Human immunodeficiency virus 1
  • gp160 protein, Human immunodeficiency virus 1